The AHEAD Study is a new trial aiming to prevent Alzheimer’s disease. It is evaluating whether an investigational treatment (BAN2401 (lecanemab)) can lower the amount of amyloid in the brain and how that impacts decline in memory loss due to Alzheimer’s.
Studies have shown that...
Location: Multiple Sites
Study Type: Prevention Studies, Studies for People without Memory Impairment
Age: 55 to 80
There are 1 in-person studies shown in alphabetical order.